A61K 31/592
9,10-secoergostane derivatives
Official title: 9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
A61K31/592 (9,10-secoergostane derivatives) appears on 219 US grants and 460 published applications in this corpus.
Search patents in A61K- Granted patents
- 219
- Published applications
- 460
- Assignees
- 230
- Inventors
- 725
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 3 | 0 |
| 1997 | 5 | 0 |
| 1998 | 12 | 0 |
| 1999 | 7 | 0 |
| 2000 | 8 | 0 |
| 2001 | 6 | 4 |
| 2002 | 3 | 5 |
| 2003 | 2 | 4 |
| 2004 | 3 | 9 |
| 2005 | 0 | 12 |
| 2006 | 5 | 9 |
| 2007 | 1 | 6 |
| 2008 | 0 | 5 |
| 2009 | 1 | 12 |
| 2010 | 1 | 14 |
| 2011 | 1 | 11 |
| 2012 | 4 | 18 |
| 2013 | 5 | 17 |
| 2014 | 7 | 32 |
| 2015 | 6 | 27 |
| 2016 | 13 | 32 |
| 2017 | 10 | 19 |
| 2018 | 20 | 29 |
| 2019 | 11 | 26 |
| 2020 | 11 | 30 |
| 2021 | 15 | 21 |
| 2022 | 15 | 24 |
| 2023 | 14 | 28 |
| 2024 | 11 | 26 |
| 2025 | 13 | 25 |
| 2026 | 4 | 15 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods for identifying pre-disposition to cognitive decline and agents for reducing or preventing cognitive decline, or improving cognitive ability29 Sep 2026US 12,746,255 B2Societe des Produits Nestle S. A.
- Methods and compositions for reducing parathyroid levels18 Aug 2026US 12,708,629 B2Eirgen Pharma Ltd.
- Transdermal delivery formulation12 May 2026US 12,622,879 B2Trs II, LLC
- Methods for identifying pre-disposition to cognitive decline and agents for reducing or preventing cognitive decline, or improving cognitive ability17 Mar 2026US 12,576,102 B2Societe des Produits Nestle S. A.
- Compositions and methods for treating neurological disorders30 Dec 2025US 12,508,250 B2
- Nutritional compositions, supplements, and fortifiers8 Oct 2026US 2026/0306432 A1Societe des Produits Nestle S. A.
- Oral composition comprising l-theanine17 Sep 2026US 2026/0272869 A1Nicoventures Trading Limited
- Oral product6 Aug 2026US 2026/0224581 A1Nicoventures Trading Limited
- Treatment of gut inflammatory diseases6 Aug 2026US 2026/0224609 A1Biokuris
- Method and Composition for an Improved Bioavailability Delivery System11 Jun 2026US 2026/0158042 A1Americana Pharma LLC
Most cited
By later US patents
- Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations63US 5,795,882 ABone Care International, Inc. · 1998
- Method for treating and preventing secondary hyperparathyroidism60US 5,707,980 ABone Care International, Inc. · 1998
- Method for treating and preventing secondary hyperparathyroidism55US 5,602,116 ABone Care International, Inc. · 1997
- Oral 1.alpha.-hydroxyprevitamin D46US 5,614,513 ABone Care International, Inc. · 1997
- Method for treating and preventing hyperparathyroidism46US 5,869,473 ABone Care International, Inc. · 1999